Purinergic signaling in cognitive impairment and neuropsychiatric symptoms of Alzheimer's disease.
Ribeiro DE, Petiz LL, Glaser T, Oliveira-Giacomelli Á, Andrejew R, Saab FAR, Milanis MDS, Campos HC, Sampaio VFA, La Banca S, Longo BM, Lameu C, Tang Y, Resende RR, Ferreira ST, Ulrich H.
Ribeiro DE, et al.
Neuropharmacology. 2023 Mar 15;226:109371. doi: 10.1016/j.neuropharm.2022.109371. Epub 2022 Dec 9.
Neuropharmacology. 2023.
PMID: 36502867
Review.